Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGRONOMICS LIMITED Net Asset Value 2013

Jul 11, 2013

7474_rns_2013-07-11_1feef045-1695-4e12-9544-42d47de7d1b4.html

Net Asset Value

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0563J

Port Erin Biopharma Investments Ltd

11 July 2013

Port Erin Biopharma Investments Limited

(the "Company")

Net Asset Value calculation to 30 June 2013

Jim Mellon, Chairman, commented: -

"The Net Asset Value ("NAV") calculation for the Company as at closing on 30 June 2013 was 10.63 pence per share, including un-invested cash of £707,624. The portfolio is valued under IFRS at bid price. This quarter's NAV represents a decrease of 5.3% from the previous valuation of 11.22 pence per share, which included un-invested cash of £287,310. However, the combined value of investments and cash at £3.625 million represents a fall of only 2.6% on the same value last period. The revenue reserve at £0.84 million still represents a return of over 33.3% on investments after listing and operating costs."

Unaudited

to 30 June 2013

£
Fixed Assets
Investments 2,916,930
Current Assets
Debtors: amounts owing 7,797
Un-invested cash 707,624
Current Liabilities
Creditors: amounts due (32,400)
3,599,951
Capital and Reserves
Share Capital 34
Share Premium 2,759,551
Current year's earnings 415,158
Retained earnings 425,208
3,599,951
Shares in Issue 33,864,836
Net Asset Value per share 10.63 pence

--- ENDS ---

Portfolio Details

Investments Schedule at 30 June 2013 £ Valuation Portfolio %
Synergy Pharmaceuticals Inc. 277,748 9.52%
Summit Corporation plc 212,500 7.29%
Arrowhead Research 207,364 7.11%
Plethora Solutions Holdings plc 166,625 5.71%
TrovaGene Inc. 137,224 4.70%
Pfizer Inc. 136,562 4.68%
Nektar Therapeutics 127,303 4.36%
Sanofi-ADR 91,349 3.13%
1,356,675 46.51%
Aggregate value of remaining holdings below 3% of total portfolio 1,560,255 53.49%
TOTAL INVESTMENTS 2,916,930 100.00%

For further information, please contact:

Port Erin Biopharma Investments Ltd Libertas Capital Corporate Finance Limited Peterhouse Capital Limited
The Company Nomad Broker
Denham Eke

+44 162 463 9396
Sandy Jamieson

+44 203 697 9495
Jon Levinson

+44 207 469 0935

This information is provided by RNS

The company news service from the London Stock Exchange

END

NAVDMGMNKGLGFZM